954 — Changmao Biochemical Engineering Share Price
Last trade - 00:00- HK$119.18m
- HK$645.27m
- CNY556.93m
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 0.2 | ||
| Price to Tang. Book | 0.2 | ||
| Price to Free Cashflow | 10.09 | ||
| Price to Sales | 0.18 | ||
| EV to EBITDA | 15.09 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | -3.71% | ||
| Return on Equity | -8.59% | ||
| Operating Margin | -3.98% | ||
Financial Summary
| Year End 31st Dec | Unit | 2021 | 2022 | 2023 | 2024 | 2025 | 2026E | 2027E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CNYm | 547.98 | 730.03 | 637.08 | 584.79 | 556.92 | n/a | n/a | 4.63% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Changmao Biochemical Engineering Co Ltd is a China-based company principally engaged in the production and sale of organic acids products. The Company’s products include organic acids and their derivatives with four carbons, such as maleic anhydride, fumaric acid, maleic acid, L-malic acid, D-malic acid, DL-malic acid, DL-tartaric acid, L-aspartic acid and aspartame and others. The Company’s products are mainly used in food additives, chemical or medical intermediaries. The Company mainly operates its businesses in the domestic and overseas markets, including Europe, Asia Pacific and America.
Directors
- Xin Sheng Rui CHM (58)
- Chun Pan CEO (45)
- Yi Dong Wan DGM (41)
- A. Xing Lu OTH (45)
- Qin Ying Zhang OTH (45)
- Pui Ling Wan SEC (43)
- Yi Xin Leng NED (53)
- Jian Ping Wang NED (53)
- Xiao Ping Yu NED (59)
- Xian Biao Zeng NED (72)
- Fung Lan Au NID (40)
- Ping Kai Ouyang NID (69)
- Xin Wei NID (47)
- Sheng Li Yang NID (74)
- Last Annual
- December 31st, 2025
- Last Interim
- June 30th, 2026
- Incorporated
- December 3rd, 1992
- Public Since
- June 28th, 2002
- No. of Employees
- 491
- Sector
- Chemicals
- Industry
- Basic Materials
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 529,700,000
- Address
- No. 1228, CHANGZHOU, 213034
- Web
- https://www.cmbec.cn
- Phone
- +86 51985776801
- Auditors
- PricewaterhouseCoopers
Latest News for 954
Upcoming Events for 954
Similar to 954
Befar
Stock Exchange of Hong Kong Limited
China Gas Industry Investment Holdings
Stock Exchange of Hong Kong Limited
Zhejiang ChangAn Renheng Technology
Stock Exchange of Hong Kong Limited
China Longevity
Stock Exchange of Hong Kong Limited
China BlueChemical
Stock Exchange of Hong Kong Limited
FAQ
As of Today at 01:54 UTC, shares in Changmao Biochemical Engineering are trading at HK$0.23. This share price information is delayed by 15 minutes.
Shares in Changmao Biochemical Engineering last closed at HK$0.23 and the price had moved by -27.42% over the past 365 days. In terms of relative price strength the Changmao Biochemical Engineering share price has underperformed the FTSE Developed Asia Pacific Index by -46.99% over the past year.
There is no consensus recommendation for this security.
Find out moreChangmao Biochemical Engineering does not currently pay a dividend.
Changmao Biochemical Engineering does not currently pay a dividend.
Changmao Biochemical Engineering does not currently pay a dividend.
To buy shares in Changmao Biochemical Engineering you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of HK$0.23, shares in Changmao Biochemical Engineering had a market capitalisation of HK$119.18m.
Here are the trading details for Changmao Biochemical Engineering:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 954
Based on an overall assessment of its quality, value and momentum Changmao Biochemical Engineering is currently classified as a Value Trap. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Changmao Biochemical Engineering. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -34.18%.
As of the last closing price of HK$0.23, shares in Changmao Biochemical Engineering were trading -22.4% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Changmao Biochemical Engineering PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at HK$0.23.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Changmao Biochemical Engineering's management team is headed by:
- Xin Sheng Rui - CHM
- Chun Pan - CEO
- Yi Dong Wan - DGM
- A. Xing Lu - OTH
- Qin Ying Zhang - OTH
- Pui Ling Wan - SEC
- Yi Xin Leng - NED
- Jian Ping Wang - NED
- Xiao Ping Yu - NED
- Xian Biao Zeng - NED
- Fung Lan Au - NID
- Ping Kai Ouyang - NID
- Xin Wei - NID
- Sheng Li Yang - NID